Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  



Merck sued over Fosamax

Lawsuits are getting under way following reports linking the osteoporosis drug, Merck's second biggest seller, to cases of necrosis (tissue death) of the jaw. Kevin Pho (first, second post) has been covering the story, as has PharmaGossip.



Rafael Mangual
Project Manager,
Legal Policy

Katherine Lazarski
Manhattan Institute


Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.